Skip to main content

Year: 2024

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

– Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – Strong balance sheet with $422.7 million in cash as of September 30, 2024 – NAARDEN, The Netherlands and MIAMI, Nov. 06, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced financial results for the three and nine months ended September 30, 2024. “We are pleased to report another strong...

Continue reading

Form 8.3 – [ECKOH PLC – 05 11 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Vishay Intertechnology to Acquire Birkelbach, Manufacturer of Metalized Technical Films

MALVERN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive electronic components, announced that it has entered into definitive agreements to acquire Birkelbach Kondensatortechnik GmbH and certain related assets (“Birkelbach”) for approximately €17 million ($18.5 million). Based in Erndtebrueck, Germany, Birkelbach is a manufacturer of metalized technical films for capacitor dielectrics. The all-cash transaction is expected to close before December 31, 2024, subject to satisfaction of customary closing conditions.  “This acquisition secures our metalized film material supply in order to meet the accelerating demand for high voltage high power film capacitors used for smart grid infrastructure projects. Birkelbach...

Continue reading

FlexShopper Partners with Aftermarket Auto Parts Alliance to Revolutionize Automotive Care Financing

Partnership with the Aftermarket Auto Parts Alliance brings FlexShopper’s proven and flexible payment solutions to more than 3,700 new retail locations Aftermarket Auto Parts Alliance is an independent network of service repair shops, including the Auto Value and Bumper to Bumper brands BOCA RATON, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq: FPAY), a prominent national online lease-to-own retailer and payment solutions provider, is proud to announce a strategic partnership with the Aftermarket Auto Parts Alliance, a large and growing collection of more than 3,700 independent distributors, auto parts stores, and professional service repair shop locations across North America. With today’s announcement, FlexShopper has expanded its payment solutions to over 7,800 locations representing a 246% increase from the...

Continue reading

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy AUSTIN, Texas and INDIANAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, and SpectronRx, a leading radiopharmaceutical contract developer and manufacturer, announced the signing of a Manufacturing Services Agreement (MSA) for the production of Rhenium (186Re) Obisbemeda, an innovative radiotherapy for CNS cancers, including leptomeningeal metastases and recurrent glioblastoma. “In 2025, we intend to begin late-stage clinical trials and are actively preparing for commercial level product demand, therefore now is the time...

Continue reading

Abcourt Confirms Gravimetric Gold Recovery from High-Grade Horse Zone on its Flordin Property

ROUYN-NORANDA, Quebec, Nov. 06, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) is pleased to announce the results of a preliminary gravity concentration test conducted on mineralized material from the high-grade gold Horse Zone. Highlights:Release of gold by coarse grinding; Mineralization similarity between 2 samples separated by one kilometer; Induced polarization geophysical work is currently underway.A 30-kilogram composite sample from channel 11 of the Horse Zone (29 g/t over 4 metres, press release dated October 24, 2024) was processed at the Corporation’s facilities. This made it possible to extract free gold by simple gravimetric concentration on a shaking table (Figure 3). The parameters set for this test made it possible to produce a coarse material...

Continue reading

Angus Gold Continues to define New Gold Zone at Dorset West, Intersects 2.3 g/t Au over 9.8 metres including 8.2 g/t Au over 2.1 metres, Golden Sky Project, Wawa

TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce assay results from nine (9) exploration holes that were completed on the Dorset Zone as part of its 2024 Summer drilling program at the Golden Sky Project in Wawa, Ontario. Drilling was targeting the western extension of the Dorset Gold Zone, where Angus previously intersected a new zone of high-grade gold, including 7.0 g/t Au over 12.4 metres in Hole GS-24-136, approximately 500 metres to the west of the historical Dorset resource (see News Release of May 7, 2024). Highlights:Successful initial step-out drilling results on the Dorset West extension area begin to define a new zone of high-grade gold mineralization in the Dorset Deformation Zone:9.8 metres of mineralization grading 2.3 g/t Au,...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 First Quarter Results

VONORE, Tenn., Nov. 06, 2024 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 first quarter ended September 29, 2024. The overview, commentary, and results provided herein relate to our continuing operations, which exclude our former Aviara segment. Overview:Net sales for the first quarter were $65.4 million, down $28.9 million, or 30.7%, from the prior-year period Income from continuing operations was $1.0 million, or $0.06 per diluted share Adjusted Net Income, a non-GAAP measure, was $1.9 million, or $0.12 per diluted share Adjusted EBITDA, a non-GAAP measure, was $3.8 million, down $10.2 million from the prior-year period Share repurchases of $3.5 million during the quarterBrad Nelson, Chief Executive Officer, commented, “Our business executed well during...

Continue reading

Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024

Conference call and webcast to begin at 8:00 AM ET BEDFORD, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it plans to host a conference call and webcast on Thursday, November 14, 2024, at 8:00 AM ET to discuss recent business progress and financial results for the third quarter ended September 30, 2024. Conference Call and Webcast Information: Date: Thursday, November 14, 2024, at 8:00 AM ET Participant Dial-In (U.S.): 1 (877) 407-9039 Participant Dial-in (International): 1 (201) 689-8470 Webcast Access: Please click here The live and archived webcast can also be accessed by...

Continue reading

Stock Yards Bancorp to Participate in the Piper Sandler 2024 East Coast Financial Services Conference

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO and T. Clay Stinnett, EVP and CFO will participate in the Piper Sandler 2024 East Coast Financial Services Conference to be held November 13th and 14th, and will participate in a series of meetings with institutional investors. Management’s discussion materials to be used at this conference will be posted to the investor section of the Company’s website, www.syb.com, on or before November 13, 2024. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $8.4 billion in assets, was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.